Yanbei Tu
Impact in
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
- Cholinesterase and Neurodegenerative Diseases
-
- Medicinal Plants and Neuroprotection
Papers in
-
- Natural product bioactivities and synthesis 12
- Bone Metabolism and Diseases 5
- Pharmacology 15
- Biological and pharmacological studies of plants 6
- Cholinesterase and Neurodegenerative Diseases 5
- Co-authors
- Yanfang Li (24 shared papers)Chengwei He (15 shared papers)Lihua Tan (8 shared papers)Kai Wang (7 shared papers)Hanqing Liu (3 shared papers)Xuejing Jia (5 shared papers)Chao Zhu (6 shared papers)Jian‐Bo Wan (5 shared papers)
In The Last Decade
Yanbei Tu
37 papers receiving 724 citations
Yanbei Tu's Hit Papers
Peers
Comparison fields: 5 of 92
- Pharmacology 126
- Complementary and alternative medicine 85
- Pharmacology 166
- Biochemistry 55
- Nephrology 62
Countries citing papers authored by Yanbei Tu
This map shows the geographic impact of Yanbei Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanbei Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanbei Tu more than expected).
Fields of papers citing papers by Yanbei Tu
This network shows the impact of papers produced by Yanbei Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanbei Tu. The network helps show where Yanbei Tu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanbei Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products Hit paper breakdown → | 2023 | 97 |
| 2 | 2019 | 73 | |
| 3 | 2017 | 47 | |
| 4 | 2022 | 46 | |
| 5 | 2021 | 46 | |
| 6 | 2021 | 37 | |
| 7 | 2015 | 29 | |
| 8 | 2024 | 27 | |
| 9 | 2019 | 26 | |
| 10 | 2019 | 23 | |
| 11 | 2020 | 22 | |
| 12 | 2023 | 21 | |
| 13 | 2022 | 20 | |
| 14 | 2019 | 20 | |
| 15 | 2018 | 19 | |
| 16 | 2019 | 18 | |
| 17 | 2019 | 16 | |
| 18 | 2020 | 16 | |
| 19 | 2023 | 15 | |
| 20 | 2020 | 13 |
About Yanbei Tu
Yanbei Tu is a scholar working on Molecular Biology, Pharmacology, Plant Science, Rheumatology and Complementary and alternative medicine, having authored 42 papers that have together received 732 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (12 papers), Phytochemistry and Biological Activities (7 papers), Biological and pharmacological studies of plants (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers), Gout, Hyperuricemia, Uric Acid (5 papers), Cholinesterase and Neurodegenerative Diseases (5 papers), Bone Metabolism and Diseases (5 papers) and Computational Drug Discovery Methods (4 papers). The work is most often cited by research in Pharmacology (126 citations), Complementary and alternative medicine (85 citations), Pharmacology (166 citations), Biochemistry (55 citations) and Nephrology (62 citations). Yanbei Tu has collaborated with scholars based in China, Macao and Spain. Frequent co-authors include Yanfang Li, Chengwei He, Lihua Tan, Kai Wang, Hanqing Liu, Xuejing Jia, Chao Zhu, Jian‐Bo Wan, Ying Yang and Qin Li. Their work appears in journals such as Phytomedicine, Natural Product Communications, Bioorganic Chemistry, Journal of Ethnopharmacology and Journal of Agricultural and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.